Browsing by Author "Amital, Howard"
Now showing items 1-5 of 5
-
Bradycardia in a patient with severe COVID-19
Zoubi, Magdi; Sheinin, Rivka; Amital, Howard; Mahroum, Naim (NLM (Medline), 2022)BACKGROUND: Heart rate disorders and in particular sinus arrhythmias are known to accompany viral infections. Sinus tachycardia is prevalent in the presence of increased body temperature and respiratory rate. However, ... -
Corrigendum to “The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual” [Autoimmunity Reviews, Volume 20 (2021) 102945]
Mahroum, Naim; Damoiseaux, Jan; Zoubi, Magdi; Lavine, Noy; Ohayon, Aviran; Amital, Howard; Shoenfeld, Yehuda (Elsevier, 2022)... -
The mosaic of autoimmunity-A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual
Mahroum, Naim; Zoubi, Magdi; Lavine, Noy; Ohayon, Aviran; Amital, Howard; Shoenfeld, Yehuda (Elsevier, 2021)Notwithstanding the fact that the 12th international congress of autoimmunity (AUTO12) was held virtual this year, the number of the abstracts submitted and those presented crossed the thousand marks. Leading investigators ... -
New-onset atrial fibrillation as poor outcome predictor in patients with severe COVID-19
Zoubi, Magdi; Hejly, Ashraf; Amital, Howard; Mahroum, Naim (NLM (Medline), 2022)Tachyarrhythmias are common in patients with coronavirus disease 2019 (COVID-19), in particular those with severe disease. However, newly diagnosed atrial fibrillation (AF) during the course of severe COVID-19 seems to ... -
Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic
Mahroum, Naim; Watad, Abdulla; Bridgewood, Charlie; Mansour, Muhammad; Nasr, Ahmad; Hussein, Amr; Khamisy-Farah, Rola; Farah, Raymond; Gendelman, Omer; Lidar, Merav; Shoenfeld, Yehuda; Amital, Howard; Kong, Jude Dzevela; Wu, Jianhong; Bragazzi, Nicola Luigi; McGonagle, Dennis (MDPI, 2021)Background. Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid ...
